Persistent nausea may also disrupt sleep patterns and overall wellbeing
Treatment stage What may be common What deserves attention Week 1 Nausea, fullness, reduced appetite, bloating, indigestion, diarrhea, constipation, fatigue Repeated vomiting, severe pain, inability to stay hydrated Weeks 2 to 4 Early symptoms may settle, persist, or fluctuate Symptoms interfering with eating, drinking, or daily function Weeks 5 to 8 Symptoms may reappear after clinician-directed dose escalation A significant return or worsening of gastrointestinal symptoms Months 2 to 3 Some patients tolerate treatment more comfortably
Many patients experience slower progress after nine to twelve months of therapy, although timing varies depending on adherence, dose optimization, and underlying metabolic conditions
The most significant ongoing concern is muscle loss during rapid weight reduction, which is why nutritional support and physician monitoring throughout treatment remain essential regardless of how long treatment lasts
Surgical interventions may be considered for select patients with advanced disease unresponsive to conservative management
1 providers serving Lee's Summit offer telehealth GLP-1 consultations
